Clinical Trial Update: Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

This update details a completed Phase 1/2 trial evaluating the safety and preliminary efficacy of P276-00 in combination with gemcitabine for advanced pancreati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemzar) (gemcitabine)
• P276-00 (P276-00)

Snippet

Sponsor: Piramal Enterprises Limited | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED